Japanese CRO Support Firm SRD Acquires Expartner Japan
This article was originally published in PharmAsia News
Executive Summary
Tokyo-based Japanese contract research organization support company SRD acquires Expartner Japan, a Tokyo-based consulting company for outsourcing medical devices and related regulatory affairs. SRD has acquired 80 percent of EPJ shares. Through the acquisition, SRD hopes to develop a synergy by combining EPJ's expertise in medical devices, related regulatory affairs and approval application support, with its own business in CRO and site management organization support, as well as good laboratory practices testing facilities. According to SRD, the company hopes the synergy will bear fruit to a whole process support system to serve both domestic and overseas medical device makers. Along with a strengthened device support business, SRD also plans to enter the regenerative medicine support business area. (Click here for more - Japanese language
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.